期刊文献+

老年患者医院下呼吸道感染碳青霉烯耐药鲍曼不动杆菌流行特征及耐药性分析 被引量:2

Investigation of the epidemiological characteristics and drug resistance of carbapenem-resistance A.baumannii in elderly patients with lower respiratory tract infection
下载PDF
导出
摘要 目的了解医院下呼吸道感染碳青霉烯耐药鲍曼不动杆菌(CRAB)的分布及耐药状况。方法回顾性分析2008年1月至2009年12月我院下呼吸道感染CRAB的流行特征。测定菌株对抗菌药物的敏感性。结果分离的CRAB大部分来自下呼吸道(82.6%),科室送检标本ICU最多(59%)。连续2年资料显示,月检出率表现为5~9月份较高。药敏结果显示,12种抗菌药物中耐药率较低的前2位依次为阿米卡星(AMK)和米诺环素(MH),分别为30.12%和43.48%。结论 CRAB以下呼吸道感染为主,集中分布于ICU,炎热时节检出率高,细菌耐药严重,宜根据药敏试验结果合理选用抗生素。 Objective To investigate the prevalence and antibiotic resistance of Carbapenem-resistance A.baumannii(CRAB) in elder patients with lower respiratory infections.Methods The reported epidemic data from Jan 2008 to Dec 2009 were analyzed retrospectively.Results Most of CRAB were isolated from lower respiratory tract(82.6%).The strains were mainly isolated from ICU(59%).Our data from consecutively 2 years showed that higher detection rate was in summer.The antibiotic susceptibility testing showed that Amikacin(with 30.12% drug resistance) and Minocyline(with 43.48% drug resistance) were the lowest drug resistant agents against CRAB.Conclusions The main site of CRAB is lower respiratory infection.The CRAB strains are mainly isolated from ICU.Drug resistance is serious,we should rationally use antibiotics according to susceptibility test results.
作者 夏瑜 张健
出处 《北京医学》 CAS 2010年第9期723-725,共3页 Beijing Medical Journal
关键词 鲍曼不动杆菌 碳青霉烯耐药 老年 A.baumannii Carbapenem-resistance Elder
  • 相关文献

参考文献6

  • 1Matthew EF, Ioannis AB, Ilias IS. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care,2006,10:R48.
  • 2Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing.Sixteenth informational supplement.Performance Standards M100-S16. Pennnsylvania: CLSI,2006:38-65.
  • 3徐礼锋,祝进,陆军,毛国刚.鲍氏不动杆菌5年感染监测[J].中华医院感染学杂志,2006,16(9):1065-1066. 被引量:26
  • 4王瑶,徐英春.2004—2005年中国CHINET鲍曼不动杆菌耐药性分析[J].中国感染与化疗杂志,2007,7(4):279-282. 被引量:71
  • 5Reinert RR, Low DE, Rossi F. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim,Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother, 2007,60:1018-1029.
  • 6Timurkaynak F, Can F, Azap OKI. In vitro activities of non -traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.Int J Antimicrob Agents,2006,27:224-228.

二级参考文献13

  • 1王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 2王辉,陈民钧,倪语星,陈冬梅,孙自庸,陈燕,赵旺胜,邹雄,俞云松,胡志东,黄心宏,徐英春,谢秀丽,褚云卓,王倩,梅亚宁,田彬,张蓓,孔庆莲,于秀娟,潘玉红.2003—2004年中国十家教学医院革兰阴性杆菌的耐药分析[J].中华检验医学杂志,2005,28(12):1295-1303. 被引量:236
  • 3杜小幸,张幸国,周华,俞云松,陈亚岗,李兰娟.亚胺培南耐药鲍曼不动杆菌同源性及碳青霉烯酶研究[J].中国感染与化疗杂志,2006,6(4):231-235. 被引量:47
  • 4Clinical and Laboratory Standards Institute 2006.Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement M100-S16[S].CLSI,2006.
  • 5Simor AE,Lee M,Vearncombe M,et al.An outbreak due to multiresistant Acinetobacter baumannii in a burn unit:risk factors for acquisition and management[J].Infect Control Hosp Epidemiol,2002,23(5):261-267.
  • 6Chastre J,Trouillet JL.Problem pathogens (Pseudomonas aeruginosa and Acinetobacter)[J].Semin Respir Infect,2000,15(4):287-298.
  • 7Dalla-Costa LM,Coelho JM,Souza HA,et al.Outbreak of carbapenem-resistant Acinetobacter baumanni producing the OXA-23 enzyme in Curitiba,Brazil[J].J Clin Microbiol,2003,41 (7):3403-3406.
  • 8Tatman-Otkun M,Gurcan S,Ozer B,et al.Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations[J].New Microbiol,2004,27(1):21-28.
  • 9Fernandez-Cuenca F,Martinez-Martinez L,Conejo MC,et al.Relationship between β-lactamases production,outer membrane protein and penicillin-binding protein profile on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J].J Antimicrob Chemother,2003,51(3):565-588.
  • 10Jeon BC,Jeong SH,Bae IK,et al.Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23β-lactamase in Korea[J].J Clin Microbiol,2005,43(5):2241-2245.

共引文献95

同被引文献32

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部